Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome

Hepato-Gastroenterology

Volumn 59, Issue 114, 2012, Pages 546-550

  Iwai, Shuji ^a   Sakaguchi, Hiroki ^b   Fujii, Hideki ^a   Kobayashi, Sawako ^a   Morikawa, Hiroyasu ^a   Enomoto, Masaru ^a   Tamori, Akihiro ^a   Kawada, Norifumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Izumi Municipal Hospital   (Japan)

Author keywords

Artificial infusion; Hepatocellular carcinoma; Radiofrequency ablation; Recurrence rate; Survival rate

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; CANCER RECURRENCE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PLEURA EFFUSION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ASCITES; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; FEMALE; GLUCOSE; HUMANS; INFUSIONS, PARENTERAL; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLEURAL EFFUSION; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84860548634     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11988     Document Type: Article

References (31)

1. Okuda K: Hepatocellular carcinoma: recent progress. Hepatology 1992; 15(5):948-963.
2. Bosch FX, Ribes J, Borràs J: Semin Epidemiology of primary liver cancer. Liver Dis 1999; 19(3):271-285. (Pubitemid 29488770)
3. El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340(10):745-750. (Pubitemid 29114292)
4. Fong Y, Sun RL, Jarnagin W, Blumgart LH: An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229(6):790-799; discussion 799-800.
5. Bruix J, Llovet JM: Prognostic assessment and evaluation of the benefits of treatment J Clin Gastroenterol 2002; Nov-Dec;35(5 Suppl 2):S138-142.
6. Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM: Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005; 31(4):331-347. (Pubitemid 40521297)
7. Lencioni RA, Allgaier HP, Cioni D: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228(1):235-240. (Pubitemid 36736097)
8. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS: Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999; 210(3):655-661. (Pubitemid 29124024)
9. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004; 127(6):1714-1723.
10. Shiina S, Teratani T, Obi S, et al.: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129(1):122-130. (Pubitemid 41002049)
11. Hori T, Nagata K, Hasuike S, et al.: Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003; 38(10):977-981. (Pubitemid 37455785)
12. Komorizono Y, Oketani M, Sako K, et al.: Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97(5):1253-62. (Pubitemid 36237312)
13. Shibata T, Iimuro Y, Ikai I, Hatano E, Yamaoka Y, Konishi J: Percutaneous radiofrequency ablation therapy after intrathoracic saline solution infusion for liver tumor in the hepatic dome. J Vasc Interv Radiol 2002; 13(3):313-315. (Pubitemid 34226420)
14. Minami Y, Kudo M, Kawasaki T, et al.: Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. J Gastroenterol 2003; 38(11):1066-1070. (Pubitemid 38016367)
15. Raman SS, Aziz D, Chang X, Sayre J, Lassman C, Lu D: Minimizing diaphragmatic injury during radiofrequency ablation: efficacy of intraabdominal carbon dioxide insufflation. AJR Am J Roentgenol 2004; 183(1):197-200. (Pubitemid 38789037)
16. Kondo Y, Yoshida H, Shiina S, Tateishi R, Teratani T, Omata M: Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract Br J Surg 2006; 93(10):1277-1282. (Pubitemid 44547029)
17. Uehara T, Hirooka M, Ishida K, et al.: Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol 2007; 42(4):306-311. (Pubitemid 46681706)
18. Mulier S, Mulier P, Ni Y, et al.: Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002; 89(10):1206-1222. (Pubitemid 36002536)
19. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN: Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226(2):441-451. (Pubitemid 36313433)
20. Seki S, Sakaguchi H, I wai S, et al.: Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy. Endoscopy 2005; 37(12):1220-1225. (Pubitemid 41763540)
21. Sakaguchi H, Seki S, Tsuji K, et al.; Japan Society for Laparoscopic Therapy Research: Endoscopic thermal ablation therapies for hepatocellular carcinoma: a multi-center study. Hepatol Res 2009; 39(1):47-52.
22. Ishikawa T, Kohno T, Shibayama T, et al.: Thoracoscope thermal ablation therapy for hepatocellular carcinoma located beneath the diaphragm. Endoscopy 2001; 33(8):697-702. (Pubitemid 32725163)
23. Teramoto K, Kawamura T, Takamatsu S, et al.: Laparoscopic and thoracoscopic approaches for the treatment of hepatocellular carcinoma. Am J Surg 2005; 189(4):474-478. (Pubitemid 40488248)
24. Holmdahl L, Risberg B: Adhesions: prevention and complications in general surgery. Eur j Surg 1997; 163(3):169-174. (Pubitemid 27104477)
25. Schäfer M, Krähenbhl L, Büchler MW: Comparison of adhesion formation in open and laparoscopic surgery. Dig Surg 1998; 15(2):148-152.
26. Song I, Rhim H, Lim HK, Kim YS, Choi D: Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 2009; 19(11):2630-2640.
27. Milingos S, Kallipolitis G, Loutradis D, et al.: Adhesions: laparoscopic surgery versus laparotomy. Ann N Y Acad Sci 2000; 900:272-285. (Pubitemid 30251478)
28. Polymeneas G, Theodosopoulos T, Stamatiadis A, Kourias E: A comparative study of postoperative adhesion formation after laparoscopic vs open cholecystectomy. Surg Endosc 2001; 15(1):41-43. (Pubitemid 32118966)
29. Lazaridis KN, Frank JW, Krowka MJ, Kamath PS: Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999; 107(3):262-267. (Pubitemid 29421593)
30. Chow KM, Szeto CC, Li PK: Management options for hydrothorax complicating peritoneal dialysis. Semin Dial 2003; 16(5):389-394. (Pubitemid 37347010)
31. Kondo Y, Yoshida H, Tateishi R, Shiina S, Kawabe T, Omata M: Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique. Br J Surg 2008; 958(8):996-1004.